Sign Up to like & get
recommendations!
0
Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.97_2631
Abstract: *Was employed by DRG Abacus at the time of analysis **Was employed by F. Hoffmann-La Roche Ltd at the time of the analysis Background: Despite improvements in DLBCL treatment, outcomes for patients with R/R DLBCL…
read more here.
Keywords:
sct ineligible;
network;
gemcitabine;
analysis ... See more keywords